Earum Pharmaceuticals Ltd - 542724 - Shareholding for the Period Ended September 30, 2019
Earum Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here10-10-2019
10-10-2019
Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for Notice Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) 2015
Earum Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2019 ,inter alia, to consider and approve the unaudited financial results of the Company for the Half Year ended on 30th September, 2019.05-10-2019
Earum Pharmaceuticals Ltd - 542724 - Closure of Trading Window
Intimation regarding Closure of Trading Window for the quarter ended 30.09.201904-10-2019
Earum Pharmaceuticals Ltd - 542724 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- BHUMISHTH NARENDRABHAI PATELDesignation :- Director04-10-2019
Earum Pharmaceuticals Ltd - 542724 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Earum Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here28-09-2019
Earum Pharmaceuticals Ltd - 542724 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sub: Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 The 7th Annual General Meeting of Earum Pharmaceuticals Limited was held on Friday, September 27,2019 commenced at 11:30 a.m. and concluded at 12:55 p.m. at the Corporate Office of the Company situated at A-1106, Empire Business Hub, Near AUDA Water Tank, Science City Road, Sola ,Ahmedabad 380060., All the resolutions had been passed with requisite majority. The detail regarding the voting results along with the copy of Scrutinizer''s Report enclosed.28-09-2019
Earum Pharmaceuticals Ltd - 542724 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the above mentioned subject, we are hereby Submitting the proceedings of the 7th Annual General Meeting held on Friday, September 27, 2019,commenced at 11:30 a.m. and concluded at 12:55 p.m. at the Corporate Office of the at A-1106, Empire Business Hub, Near AUDA Water Tank, Science City Road, Sola Ahmedabad-380060,Gujarat.India.27-09-2019
Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Change in Directorate
1.Appointment of Mr.Bhavik Shantilal Patel as the Additional Director, Non-Executive- Independent Director his Appointment as Independent Director is subject to approval of shareholders at the ensuing Annual General Meeting of the Company. Information under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is enclosed herewith. 2.We further inform you that Mr. ALPESH FATEHSINGH PUROHIT (Non-Executive -Independent Director) has resigned from the Board with immediate effect from 12/09/2019 due to her pre-occupations.12-09-2019
Earum Pharmaceuticals Ltd - 542724 - Reg. 34 (1) Annual Report
Pursuant to Regulation 34(1) of SEBI (LODR) Regulation, 2015 enclosed is a copy of the Revised Annual Report being sent to the shareholders which contains the Notice of the Annual General Meeting of the Company. We informed there was typographical /copy paste mistake in following sub note, which is uploaded as on 04/09/2019, we rectified that copy paste mistake, There was no change in financial data. Following Sub Note change in Annual Report-2018-19. 1.Sub Note 1 : Unsecured Loan Page:50 2.Sub Note 2 : Trade Payable Page:50-51 3.Sub Note 3: Other Current Liability Page:52 4.Sub Note 4: Short term Loans & Advances Page:53 5.Sub Note 5: Current Bank Accounts Page:53 6.Sub Note 6: Sundry Debtors Page:54-5610-09-2019
Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Resignation of Director
1. We wish to inform you that Mr.Narendrakumar Gangaramdas Patel(DIN:07017438), Non Executive Director, of our Company,has submitted his letter of resignation dated September 7th ,2019 resigning as Director and Non Executive Director of our Company on account of certain personal reasons. 2. The Board of Directors ('the Board), at its meeting held today, September 7th,2019,has accepted Mr.Narendrakumar Gangaramdas Patel resignation and consented to relieve him of his responsibilities with effect from September 7th ,2019. 3.This letter treated as communication under Regulation 30 and other applicable provisions, if any, of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.07-09-2019